AI Science Tracker
EN

OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.

1 discovery from 2024

Discoveries

Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [ 11 C] methionine PET and T1c-w MRI.

Source check: Source checked. Not independent scientific confirmation.

Finding: original article tests radiomics/deep-learning methods on PET/MRI for residual tumour detection and outcome prediction; independent test supports detection claim, prognostic estimates remain cohort-bound. AI role: Radiomics and 3D convolutional neural networks on MET-PET and MRI. The article appeared in Scientific Reports.

Technology: Radiomics and 3D convolutional neural networks on MET-PET and MRI

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Radiomics and 3D convolutional neural networks on MET-PET and MRI
Test and result
original article tests radiomics/deep-learning methods on PET/MRI for residual tumour detection and outcome prediction; independent test supports detection claim, prognostic estimates remain cohort-bound.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/38403632 · https://inrepo02.dkfz.de/record/288579/files/s41598-024-55092-8.pdf?version=1 · https://pubmed.ncbi.nlm.nih.gov/38403632/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.